Abstract
BACKGROUND Heavy menstrual bleeding (HMB) is a common type of menstrual disorder that causes social and mental distress leading to a variety of health problems. Although limited evidence highlights the links between HMB and metabolic abnormalities, the association between HMB and CVD outcomes is unknown in the presence or absence of comorbid irregular menstruation (IM).
METHODS All female hospitalizations between the ages of 12 to 40 years were identified using the National Inpatient Sample database in 2017 and grouped into HMB and no menstrual disorders. Outcomes including major adverse cardiovascular events (MACE), coronary heart disease (CHD), stroke/cerebrovascular accident (CVA), heart failure (HF), arterial fibrillation (AF) or arrhythmia, myocardial infarction (MI), and diabetes (DM) were extracted using ICD-10 codes. Adjusted logistic regression models were conducted to summarize associations with an odds ratio (OR) along with a 95% confidence interval (CI).
RESULTS In the entire cohort, 8,291 (0.69%) had an HMB diagnosis including 1623 (0.14%) with IM and 6668 (0.55%) without IM. In the fully adjusted analysis, HMB was significantly associated with most CVD outcomes, including MACE (OR=1.61; 95% CI: 1.38, 1.88, p<0.001), CHD (OR=1.88; 95% CI: 1.52, 2.31, p<0.001), Stroke/CVA (OR=1.51; 95% CI: 1.1, 2.07, p=0.011), HF (OR=1.60; 95% CI: 1.33, 1.92, p<0.001), AF/arrhythmia (OR=1.93; 95% CI: 1.16, 2.45, p=0.006), and DM (OR=1.45; 95% CI: 1.33, 1.58), p<0.001). HMB without IM was strongly associated with DM, HF, AF, and MACE outcomes while HMB with IM was strongly associated with CHD and AF outcomes.
CONCLUSIONS HMB is independently and strongly associated with CVD events among US hospitalizations of young women. Our findings suggest promoting increased awareness, early detection, and optimum management of HMB to avoid adverse CVD outcomes.
What Is New?
Although menstruation dysfunction is associated with cardiovascular disease (CVD), the relationship between heavy menstrual bleeding (HMB) and CVD outcomes is not evaluated.
In a US sample of 1,204,715 hospitalized women, HMB was independently and strongly associated with major adverse cardiovascular events and coronary heart disease.
HMB without irregular menstruation was markedly associated with CVD outcomes than HMB with irregular menstruation.
What Are the Clinical Implications?Our findings support that HMB as an early vital sign for CVD outcomes among young women. A routine investigation and screening of menstrual disorders, especially HMB, and its effective management is useful for the prevention of CVD risk in women.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Not applicable.
Funding Statement
No external funding was received for this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The NIS, 2017 includes de-identified datasets from the International Classification of Diseases, 10th Revision (ICD-10) codes from participating hospitals and hence, does not require participant consent or approval.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
All the study data are available at National (Nationwide) Inpatient Sample (NIS) and can be purchased and access through the website: https://hcup-us.ahrq.gov/nisoverview.jsp
